epocrates logo
epocrates logo
epocrates logo
  • 0

Government Health Agency News

FDA

FDA OKs first oral contraceptive designed for individuals who have trouble swallowing

July 25, 2024

card-image

Earlier this week FDA approved norethindrone acetate and ethinyl estradiol (Femlyv), the first orally disintegrating tablet approved for the prevention of pregnancy. Norethindrone acetate and ethinyl estradiol have been approved in the U.S. for the prevention of pregnancy as a swallowable tablet since 1968. Tap for the full prescribing information ...

Trending icon

TRENDING THIS WEEK

EPOCRATES CME

View Catalog

view all CME activities
learn more about epocrates plus
Clinical FAQ icon

Clinical FAQs

Check out the answers to frequently asked questions about our clinical content.

Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & Feedback
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information